Topic
Biotech
3 articles
SPAC Mergers
424B4 Prospectus: Black Hawk SPAC Merger Values Vesicor at $70M
Black Hawk Acquisition Corp filed a 424B4 proxy and prospectus for its merger with biotech Vesicor Therapeutics at a $70 million equity value; vote set Oct. 13.
IPO
Electra Therapeutics IPO Pricing: $350 Million at $15 a Share
Electra Therapeutics priced 23.3 million shares at $15 in its September 2026 Nasdaq IPO. Our review of the 424B4 prospectus, pipeline, losses and cash.
IPO
Kardigan IPO Pricing: $400 Million Raised at $16 a Share
Cardiovascular biotech Kardigan priced 25 million shares at $16 in its June 2026 Nasdaq IPO. Our 424B4 review covers proceeds, pipeline, losses and cash.